Trypanosoma cruzi, the causative agent of Chagas' disease, which is widely disseminated in Central and South America, represents an endemic neglected disease located in this geographic region. Therefore, there is an urgent need for the discovery of new, more effective, and safer drugs for human use.
Introduction
Despite the fact that Carlos Chagas described, near to a century ago 1 the vector, microorganism and clinical signs, American Trypanosomiasis (or Chagas disease) remains the largest parasitic disease burden on the American continent. This disease is widely disseminated in Central and South America and represents an endemic disease in 21 countries located in this geographic region. It has been estimated that this disease affects 9.8 to 11.0 million people, and 60.0 million are at risk. 2 Like other neglected diseases, it is an important health problem due to inadequate therapy and the lack of an effective vaccine. 3 Nufurtimox (Nfx) and benznidazole (Bz) are the only licensed drugs for Chagas' disease which have shown clinical efficacy, but they are far for being optimal due to their low effectiveness in chronic phase and they adverse effects. 4 Currently, optimal curative treatments for Chagas disease do not exist and therefore, all the possible efforts are necessary in the search of effective treatment for this disease.
Therefore, there is an urgent need for the discovery of new, more effective, and safer drugs for human use. One of such important drug targets receiving considerable attention is the enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH; EC 1.2.1.12), a key protein in the glycolytic pathway of trypanosomatids. Several studies have been carried out, observing the inhibitory properties of many coumarins for this enzyme 4 , 5 , 6 During the course of T. cruzi infection and disease development, reactive oxygen species (ROS) can be produced as a consequence of tissue destruction caused by toxic secretions of parasite, immune-mediated cytotoxic reactions, and secondary damage in the myocardium. Therefore, interventions with antioxidant compounds that reduce the generation or the effects of ROS, may exert beneficial effects in preventing or arresting the oxidative damage.
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The use of natural products and synthetic derivatives is widely extended against protozoal infection and they have been studied and evaluated against T. cruzi. 8 Chalcones It is known that the antioxidant properties of chalcones are quite dependant on the two aryl structures, that is, the substitution pattern on the two aryl rings of the chalcone moiety.
Especially, the hydroxyl substituent is one of the key groups that enhance greatly the antioxidant activity of chalcone mainly due to its easy conversion to phenoxy radicals through the hydrogen atom transfer mechanism. This phenoxy radical formation may be crucial to the antioxidant properties, which are assessed primarily as radical scavenging potential of phenolic chalcones. In fact, the hydroxyl substituent is common among chalcones from natural sources. 21 On the other hand, coumarins are a large family of compounds, of both natural and synthetic origin, important because of the pharmacological activities that these kind of compounds display, such as antimicrobial, 22 Due to the potential antioxidant and trypanocidal activity of the chalcone and coumarin moieties, in the present work a series of coumarin-chalcone hybrids have been synthesized and it has been studied their antioxidant and anti-trypanosomal activity (Scheme 1).
Scheme 1.
Rational design of coumarin-chalcone hybrid compounds
Results and Discussion

Chemistry
The synthesis of the final tested compound (1-4) was carried out in two steps briefly described 
Electrochemical study
It is known that the antioxidant capacity is possibly related to the electrochemical behaviour, being indicative that the lower oxidation potential the higher antioxidant capacity. for several scan rates (v). In these experimental conditions, two oxidation processes (peaks I, II)
were observed. In general, it has been proposed that the charge transfer process at peak I corresponds to the oxidation of the catechol substituent, while the others peaks (II) comprise oxidation reactions involving the hydroxyl groups present in the coumarinic ring, respectively. Results of the oxidation potential of compounds 1-4 are summarized in Table 1 . We can observe that coumarin-chalcone hybrids present low oxidation potential. This fact can be explained principally by the strong electron donating effect of catechol group, present in all the tested compounds. The capacity of scavenging peroxyl radicals was studied through the oxygen radical absorbance capacity (ORAC) method. In this assay, Trolox and 2,2'-Azo-bis(2-amidinopropane) 
Trypanosomal activity
The antitrypanosomal activity for all synthesized compounds was evaluated using MTT assays. 33 The results reported in Table 3 have shown that all compounds present weak antitrypanosomal activity being less activity than the positive control nifurtimox. 
Conclusions
In conclusion, we have confirmed the considerable antioxidant activity of new hydroxylated coumarin-chalcone hybrid compounds 1-4. Their antioxidant activity is affected by the introduction of a benzoyl moiety at the C3 position regarding to the coumarin ring. A very interesting finding is that compound 1 is very reactive and presents good antioxidant capacity against hydroxyl and peroxyl radicals as well as low oxidation potential.
In spite of the moderate trypanocidal activity of coumarin-chalcone hybrids, they have been proved to be very good antioxidants. Based on these results, we can conclude that compounds 2 and 3 are potential candidates for in vitro studies of their antioxidant activity.
Experimental
Melting points were determined using a Reichert Kofler thermopan or in capillary tubes on a
Büchi 510 apparatus and are uncorrected. 
General procedure for the synthesis of 3-benzoylcoumarins I-IV:
To a solution of the appropriate β-ketoester (1 equivalent) and the corresponding salicylaldehyde (1 equivalent) in ethanol was added piperidine in catalytic amount. The reaction mixture was refluxed for 2-5 h and after completion (followed by TLC), the reaction was cooled and the precipitated was filtered and washed with cold ethanol and ether to afford the desired compound. Compounds were further recrystallized in methanol/CH 2 Cl 2 . 
3-(3',4'-Dimethoxybenzoyl)coumarin
6-Bromo-3-(3',4'-dimethoxybenzoyl)-8-methoxycoumarin
6-Methyl-3-(3',4'-dimethoxybenzoyl)coumarin
General procedure to the synthesis of the hydroxylated 3-benzoylcoumarins (1-4):
To the corresponding methoxy-3-benzoylcoumarin (1 mmol) in DCM, BBr 3 in DCM (20 mmol, 1M) was added in a Schlenk tube. Tube was sealed, and the reaction mixture was heated at 80ºC for 48 h. The resulting crude was treated with MeOH and rotated to dryness. The obtained precipitated was recrystallized in MeOH or purified by flash chromatography using hexane/ ethyl acetate as mixtures as eluent, to afford the desired hydroxy derivative. 
ORAC-FL
The ORAC-FL assays were carried out on a Synergy HT multi detection microplate reader, 
Scavenging assays
A mixture of 100 µL water with 50 µL NaOH (final concentration 4 mM) follow by addition of 50 µL DMPO spin trap (30 mM final concentration) and 50 µL H 2 O 2 30% and finally 50 µL of antioxidant compound dissolved in N,N-dimethylformamide. The mixture was put in EPR Cell and we recorded spectrum after five minutes of reaction. All derivatives were studied to 3 mM final concentration.
Trypanosomal activity
Trypanocidal activity was evaluated against the T. cruzi epimastigote stage (clone Dm28c).It was measured through the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5diphenyltetrazolium bromide) assay, using 0.22 mg mL -1 phenazine metosulfate (as electron carrier). In this colorimetric assay for testing the antitrypanosomal activity, the coumarin-chalcone hybrids, dissolved in DMSO were added to 3 x 10 6 parasites mL -1 at 10 and 100 µmol L -1 final concentrations in RPMI 1640 culture medium (5% bovine fetal serum) for 24 h at 28°C. DMSO final concentration was less than 0.1% v/v. Likewise, nifurtimox was added as positive control.
Tetrazolium salt was added at a final concentration of 0.5 mg mL -1 , incubated at 28°C for 4 h and then solubilized with 10% sodium dodecyl sulfate/0.1 mmol L -1 HCl and incubated overnight. After incubation time, we determined the number of viable parasites by absorbance measures at 570 nm in a multiwell reader (Asys Expert Plus©, Austria). Untreated parasites were used as controls (100% of viability). Results are reported as the percentage of non-viable epimastigotes regarding the control.
